Novagem Ltd and Astellas have entered into a partnership for the promotion and distribution of Astellas’ products portfolio in Cyprus.
Astellas Pharma Inc., based in Tokyo, Japan, was established in Apr. 1, 2005, after the merger of the mother companies Yamanouchi (founded in 1923 in Osaka, Japan) and Fujisawa (founded in 1894 in Osaka, Japan).
In Europe, Astellas Pharma Europe Ltd. operates in 37 countries, speaking 23 main languages and has 3.500 employees. The headquarters are based in the UK, and support the affiliate teams across Europe, Australia, and Canada, working in collaboration with the Manufacturing and Medical & Development sites in Ireland and the Netherlands.
Astellas invests in new medicines, technologies and therapeutic areas to stay at the cutting-edge of science and builds partnerships and networks with others who share its vision to improve the future of medicine.